Treatment | 8 d after injection1-a | 32 d after injection1-a | ||
---|---|---|---|---|
Lamina I–III | Lamina V and VI | Lamina I–III | Lamina V and VI | |
None | 1.79 ± 0.44 | 0.021 ± 0.029 | ||
LacZ/Adts | 1.82 ± 0.40 | 0.042 ± 0.032 | ||
N-Cad/Adts | 1.91 ± 0.24 | 0.005 ± 0.007 | ||
L1/Adts | 1.83 ± 0.25 | 0.009 ± 0.016 | ||
NT-3/Adts | 1.96 ± 0.41 | 0.010 ± 0.019 | 1.80 ± 0.20 | 0.007 ± 0.008 |
NGF/Adts | 2.27 ± 0.45* | 0.215 ± 0.161** | 2.39 ± 0.35** | 2.672 ± 0.441** |
FGF-2/Adts | 1.96 ± 0.25 | 0.008 ± 0.017 | 1.93 ± 0.22 | 0.004 ± 0.005 |
Each treatment represents data taken from not less than three rats. ± SD; *p > 0.05, **p > 0.01.
↵F1-a Optical density measurement indicating axon densities taken from individual regions in lamina I–III (illustrated as A′ in Fig. 3B) or lamina V and VI (illustrated as B′ in Fig. 3B).